Clinical outcomes of arthroscopic all-inside anterior talofibular ligament suture augmentation repair,PLUS suture augmentation repair and anterior tibiofibular ligament distal fascicle transfer augmentation repair
Objective:To explore the short-term clinical efficacy of anterior talofibular ligament(ATFL)suture augmentation repair,PLUS suture augmentation repair and anterior tibiofibular ligament's distal fascicle(ATiFL-DF)transfer augmentation repair under arthroscopy.Methods:The retrospective study included a cohort of sixty-seven patients who underwent surgical treatment for an anterior talofibular ligament(ATFL)injury between June 2019 and February 2021,with a follow-up period of two years.The patient groupings consisted of 25 individuals who underwent ATFL suture augmentation repair(suture group),22 who received the PLUS suture augmentation repair(PLUS suture group),and 20 who were treated with ATiFL-DF transfer augmentation repair(biological group).Postoperative evaluations were conducted using a suite of standardized measures,including the American orthopaedic foot and ankle society(AOFAS)score,foot and ankle ability measure(FAAM)score,visual analogue scale(VAS)score,and stress radiographs.Results:At 1 and 3 months postoperatively,the AOFAS score of patients in the biological group was significantly lower than that in the suture group and PLUS suture group(AOFAS score of 1 month is 78.2±7.2,83.7±5.7 and 85.0±6.2 in biological group,suture group and PLUS suture group respectively,P=0.002;AOFAS score of 3 months is 86.9±4.3,91.2±3.6 and 91.8±3.7 in biological group,suture group and PLUS suture group respectively,P<0.001).At 1 and 3 months postoperatively,the VAS scores in the biological group were significantly higher than those in the suture group and PLUS suture group(VAS score of 1 month is 3.5±1.2,2.6±1.1 and 2.8±0.8 in biological group,suture group and PLUS suture group respectively,P=0.001;VAS score of 3 months is 2.9±1.1,2.1±1.3 and 2.0±1.0 in biological group,suture group and PLUS suture group respectively,P=0.001).In addition,6 months,12 months,and 24 months postoperatively,there were no significant differences among the three treatment groups in terms of AOFAS,VAS,FAAM,and stress radiogram(P>0.05).Conclusion:ATFL suture augmentation repair,PLUS suture augmentation repair,and ATiFL-DF transfer augmentation repair have all demonstrated efficacious therapeutic outcomes.However,it was observed that the early postoperative pain experienced by patients who underwent the ATiFL-DF transfer augmentation repair was more intense when compared to those who received suture augmentation repair and PLUS suture augmentation repair.